Srividya Ramachandran

Interferon-Induced Ifit2/ISG54 Protects Mice from Lethal VSV Neuropathogenesis

Volker Fensterl, Jaime L. Wetzel, Srividya Ramachandran et al. · PLoS Pathogens · 2012 · 174 citations · Full text

Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis

Robert J. Fox, Christopher S. Coffey, Merit Cudkowicz et al. · Contemporary Clinical Trials · 2016 · 66 citations · Full text

Neurological Disorder, Clinical Neurology, Clinical Trials +6

Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters

Srividya Ramachandran, Jared E. Knickelbein, Christina Ferko et al. · Virology · 2008 · 41 citations · Full text

Molecular Virology, Medicine, Natural Sciences +11

Delaying the Expression of Herpes Simplex Virus Type 1 Glycoprotein B (gB) to a True Late Gene Alters Neurovirulence and Inhibits the gB-CD8 ⁺ T-Cell Response in the Trigeminal Ganglion

Srividya Ramachandran, Katherine Davoli, Michael B. Yee et al. · Journal of Virology · 2010 · 25 citations · Full text

Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells

Benjamin R. Treat, Sarah M. Bidula, Srividya Ramachandran et al. · PLoS Pathogens · 2017 · 18 citations · Full text

Target Hierarchy, Viral Latency, Autoimmune Disease +15